Renal transplantation 2004: where do we stand today?
- PMID: 15574992
- DOI: 10.1093/ndt/gfh511
Renal transplantation 2004: where do we stand today?
Abstract
In spite of considerable progress in immunosuppressive and supportive treatment, numerous problems persist which interfere with the success of renal transplantation. Before transplantation has been performed, factors impacting on outcome include the donor (living vs cadaver, age and HLA system) as well as the recipient (age, immunological reactivity, potential sensitization and duration of dialysis). These are the main factors that affect the outcome of the transplant, particularly in the long-term. After transplantation a number of events may put graft function at risk: potential recurrence of the primary renal disease in the allograft; 'de novo' renal disease triggered by infections, drugs or autoimmunity; and non-specific progression promoters, such as diabetes, hypertension, proteinuria, nephrotoxic agents and/or viral infections. The two most frequent causes of chronic allograft dysfunction are (i) chronic rejection (often triggered by preceding acute rejection, delayed graft function or poor compliance) and (ii) calcineurin-inhibitor nephrotoxicity (more likely to develop in kidneys of older donors or in marginal kidneys). The differential diagnosis between these two entities is generally difficult, but some histological clues (reduplication of glomerular basement membrane, obliterating vasculopathy and C4d deposits) as well as the demonstration of humoral antibodies are pointers suggesting rejection. Treatment of chronic graft dysfunction is difficult, whatever the cause, particularly in cases with advanced renal lesions. Therefore, early diagnosis is of paramount importance. In this regard, graft biopsy can be of great help. In spite of many problems and complications, not only short-term but also long-term results of renal transplantation are improving progressively, as documented by CTS data showing that in Europe for transplants performed between 1982 and 1984 the mean graft half-life was 7 years, while for transplants performed between 1997 and 1999 it was 20 years.
Similar articles
-
The Bergamo Kidney Transplant Program.Clin Transpl. 2005:85-100. Clin Transpl. 2005. PMID: 17424727
-
Factors influencing long-term outcomes following renal transplantation: a review.JNMA J Nepal Med Assoc. 2007 Jul-Sep;46(167):136-42. JNMA J Nepal Med Assoc. 2007. PMID: 18274571 Review.
-
Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.Transplant Proc. 2007 Sep;39(7):2123-4. doi: 10.1016/j.transproceed.2007.06.034. Transplant Proc. 2007. PMID: 17889112
-
Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.Nephrology (Carlton). 2008 Feb;13(1):80-6. doi: 10.1111/j.1440-1797.2007.00866.x. Nephrology (Carlton). 2008. PMID: 18199109
-
Problems in the long-term renal allograft recipient.Crit Care Clin. 1990 Oct;6(4):979-1005. Crit Care Clin. 1990. PMID: 2265390 Review.
Cited by
-
An N-linked glycoprotein with alpha(2,3)-linked sialic acid is a receptor for BK virus.J Virol. 2005 Nov;79(22):14442-5. doi: 10.1128/JVI.79.22.14442-14445.2005. J Virol. 2005. PMID: 16254379 Free PMC article.
-
Direct correlation between sialic acid binding and infection of cells by two human polyomaviruses (JC virus and BK virus).J Virol. 2008 Mar;82(5):2560-4. doi: 10.1128/JVI.02123-07. Epub 2007 Dec 19. J Virol. 2008. PMID: 18094176 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials